2022. Gender and clinical trials: is the Regulation n. 536/2914 (EU) a missed opportunity?. TEST BioLaw Journal - Rivista di BioDiritto. 4 (Dec. 2022), 251–276. DOI:https://doi.org/10.15168/2284-4503-2478.